Divi's Laboratories Limited - Company Profile

It is a pharma public limited company based in Hyderabad, Telangana, India, established in 1990.
1990 Hyderabad, Telangana, India Active
Last Updated:
About Divi's Laboratories Limited

Divi's Laboratories Limited, a active public limited company, was established on 12 October 1990 in Hyderabad, Telangana, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: L24110TG1990PLC011854. Registered under ROC Roc Hyderabad. it is listed on BSE: 532488 and NSE: DIVISLAB. It has an authorized capital of ₹60.00 Cr and a paid-up capital of ₹53.09 Cr.

Formerly known as Divi's Research Centre Private Limited, Divi's Laboratories Private Limited. It upholds a compliant status. In 2023, it reported revenue of ₹7,974.31 Cr and a net worth of ₹12,705.42 Cr. Employing 11,560 professional, Its leadership includes Nimmagadda Venkata Ramana (Whole-Time Director), Murali Krishna Prasad Divi (Managing Director), Ganapaty Seru (Director). Past directors included Nimmagadda Venkata Ramana, Murali Krishna Prasad Divi, Ganapaty Seru. It holds ₹515.00 Cr open charges and ₹671.72 Cr settled loans. Its latest AGM occurred on 11 August 2025, with the balance sheet filed on 31 March 2025. It is based at 1-72/23(P)/Divis/303, Divi Towers Cyber Hills, Gachibowli, Hyderabad, Telangana, 500032.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    L24110TG1990PLC011854

  • Registration Number

    011854

  • Incorporation Date

    12 October 1990

  • Authorized Capital

    ₹60.00 Cr

  • Paid-Up Capital

    ₹53.09 Cr

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Listed (BSE: 532488, NSE: DIVISLAB)

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 60.00 Cr
  • Paid Up Capital ₹ 53.09 Cr
  • Company Age 35 Year, 4 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 515.00 Cr
  • Satisfied Charges ₹ 671.72 Cr
  • Revenue Growth **** -11.31%
  • Profit Growth **** -38.68%
  • Ebitda **** -39.44%
  • Net Worth 8.67%
  • Total Assets **** 7.84%
Company report

Divi's Laboratories Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Divi's Laboratories Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Divi's Laboratories Limited?
Current Directors
Name Designation Appointment Date Status
Nimmagadda Venkata Ramana Whole-Time Director 01 Oct 1994 Current
Murali Krishna Prasad Divi Managing Director 12 Oct 1990 Current
Ganapaty Seru Director 22 Jul 2017 Current
Sunaina Singh Director 28 Mar 2019 Current
Rajendra Kumar Premchand Director 25 May 2024 Current
Motaparti Nilima Whole-Time Director 27 Jun 2017 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 26 Dec 2009 Past
Pramod Abcsdd Managing Director 31 Mar 2020 Past
Pramod Abcsdd Additional Director 25 Sep 2017 Past
Pramod Abcsdd Additional Director 05 Aug 2013 Past
Pramod Abcsdd Additional Director 23 Aug 2019 Past
Pramod Abcsdd Director 22 Jun 2017 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Divi'S Laboratories.

Divi'S Laboratories Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 11.31% decrease. The company also saw a substantial fall in profitability, with a 38.68% decrease in profit. The company's net worth moved up by a moderate rise of 8.67%.

Divi'S Laboratories revenue growth over time
Divi'S Laboratories profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
-11.31%
*******
*******
*******
*******
Revenue from Operations
*******
-14.13%
*******
*******
*******
*******
Total Assets
*******
7.84%
*******
*******
*******
*******
Profit or Loss
*******
-38.68%
*******
*******
*******
*******
Net Worth
*******
8.67%
*******
*******
*******
*******
EBITDA
*******
-39.44%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Divi'S Laboratories?

In 2023, Divi'S Laboratories had a promoter holding of 51.94% and a public holding of 48.05%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹5,150,000,000.00

Satisfied Charges

₹6,717,180,000.00

Charges Breakdown by Lending Institutions
  • State Bank Of India : 454.50 Cr
  • Hdfc Bank Limited : 60.50 Cr
Latest Charge Details
Date Lender Amount Status
27 Feb 2019 Hdfc Bank Limited ₹60.50 Cr Open
14 Dec 1995 State Bank Of India ₹454.50 Cr Open
28 Oct 2006 The Bank Of Nova Scotia ₹20.90 Cr Satisfied
15 Jun 2006 State Bank Of India - Overseas Branch ₹50.58 Cr Satisfied
28 Dec 2005 Bank Of Nova Scotia ₹20.00 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Divi'S Laboratories?

Divi'S Laboratories has a workforce of 11560 employees as of Sep 10, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Divi'S Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Divi'S Laboratories's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Divi'S Laboratories
Recent Activity within the Organization
  • Annual General Meeting

    The activity Divi'S Laboratories Limited last Annual general meeting of members was held on 11 Aug 2025 as per latest MCA records. was completed.

  • Balance Sheet

    The activity Divi'S Laboratories Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was completed.

  • Director Appointment

    Progress on Rajendra Kumar Premchand was appointed as a Director was appointed as a Director on 25 May 2024 & has been associated with this company since 1 year 8 months . was documented.

  • Director Appointment

    Devendra Rao Sureddy was appointed as a Whole-time director was appointed as a Whole-time director on 10 Feb 2024 & has been associated with this company since 2 years . was recorded as a recent event.

  • Charges

    The activity A charge with State Bank Of India of Rs. 454.50 Cr registered on 14 Dec 1995 with Charge ID 90137808 was modified on 07 Apr 2022. was completed.

  • Charges

    Progress on A charge with Hdfc Bank Limited of Rs. 60.50 Cr registered on 27 Feb 2019 with Charge ID 100246839 was modified on 10 Mar 2022. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Divi's Laboratories Limited?

The CIN of Divi's Laboratories Limited is L24110TG1990PLC011854.

Where is Divi's Laboratories Limited headquartered?

Divi's Laboratories Limited is headquartered at 1-72/23(P)/Divis/303, Divi Towers Cyber Hills, Gachibowli, Hyderabad, Telangana, 500032.

When was Divi's Laboratories Limited incorporated?

Divi's Laboratories Limited was incorporated on 12 October 1990.

Who are the current directors of Divi's Laboratories Limited?

The current directors of Divi's Laboratories Limited are

What is the primary industry of Divi's Laboratories Limited?

The primary industry of Divi's Laboratories Limited is Manufacturing.

Is Divi's Laboratories Limited a listed company?

Divi's Laboratories Limited is listed. It is listed on BSE: 532488 and NSE: DIVISLAB.

What is the capital structure of Divi's Laboratories Limited?

The authorized capital of Divi's Laboratories Limited is ₹60.00 Cr, and the paid-up capital is ₹53.09 Cr.

What is the compliance status of Divi's Laboratories Limited?

The compliance status of Divi's Laboratories Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available